Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
A nurse in blue protective gear carries boxes of COVID-19 vaccine in Caracas, Venezuela.(Source:Alamy)
Manufacturers can distribute masks, diagnostics and other equipment key to the fight against COVID-19 in Iran, Syria and Venezuela, thanks to the Biden administration’s decision to temporarily lift some sanctions against the countries.
The exemptions expand current humanitarian exceptions to the sanctions and will expire in June 2022. The US Treasury Department says the move was made in response to a national security memo from President Joe Biden that directed federal agencies to review whether existing US sanctions were harming international efforts against COVID-19.
Equipment specifically protected by the new exemptions include face masks, ventilators and oxygen tanks, vaccines and tools needed for the production of vaccines, COVID-19 tests, air filtration systems, and COVID-19-related field hospitals, Treasury said. The department also released some guidelines and FAQs more specifically explaining what is and isn’t allowed.
“These new authorizations will further support the critical work of governments, international organizations, non-governmental organizations and private sector actors in providing COVID-19-related assistance to the people in certain sanctioned jurisdictions.” – US Treasury
“These new authorizations will further support the critical work of governments, international organizations, non-governmental organizations and private sector actors in providing COVID-19-related assistance to the people in certain sanctioned jurisdictions,” Treasury said.
Normally, organizations that want to export medical equipment to countries that are under sanction by the US need to apply to Treasury for a special exemption. When the national public health emergency began in March of last year, the department agreed to prioritize and expedite requests to send devices to Iran but kept the sanctions mostly in place. The new general licenses allow for a limited range of medical equipment to be shipped to the countries without specific permission.
Humanitarian and civil rights organizations had been asking for broader sanctions relief in light of COVID-19 for some time. On 26 March, 55 groups including Amnesty International, Veterans for Peace, CODEPINK and several religious denominations sent a letter to Biden asking for a global general license allowing export of all equipment needed to fight the pandemic.Medtech Insight: global medical technology news & analysis
By Amanda Maxwell 23 May 2022
This is a landmark month with the expiry this week of the IVD Directive. May has also seen a flurry...
Medtech Insight: global medical technology news & analysis
By Amanda Maxwell 23 May 2022
In the EU, lack of regulatory predictability is creating frustration, sending innovators across the Atlantic, and has been a factor...
Medtech Insight: global medical technology news & analysis
By Shawn Schmitt 23 May 2022
The makers of breathing machines said in comments to the US agency that it must address language in its draft...
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
Looking for more products Product Finder
